TickerFacts.

Company research / SVA

Sinovac Biotech Ltd (SVA)

Build a valuation ↗↓ Download CSV

SEC name SINOVAC BIOTECH LTD · CIK 0001084201 · Nasdaq · Pharmaceutical Preparations

  • Sector Manufacturing
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, Sinovac Biotech Ltd reported revenue of $386.01M. Revenue grew 6.8% from the prior annual period.

Key ratios (year ended 2025-12-31)

67.9%
Gross margin
-127.0%
Operating margin
-51.5%
Net margin
-3.1%
Return on year-end equity
6.8%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 6-K (current report) · 2026-08-17

Headquarters locality: Beijing / · View on map

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

Period ended2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenue$386.01M$361.37M$470.17M$1.47B$19.37B$510.62M$246.05M$229.65M$174.35M$72.43M
Cost of Revenue$124.03M$140.69M$146.85M$658.19M$988.92M$67.18M$32.47M$24.72M$20.24M$22.39M
Gross Profit$261.98M$220.69M$323.32M$815.24M$18.38B$443.44M$213.58M$204.93M$154.11M$50.04M
R&D Expense$216.18M$270.66M$350.19M$478.69M$152.70M$48.76M$24.25M$21.91M$20.49M$12.65M
Operating Income-$490.13M-$505.54M-$713.98M-$508.99M$17.62B$215.64M$68.56M$45.32M$45.42M$504.0K
Net Income-$198.84M$40.66M-$120.86M-$59.97M$14.12B$185.18M$65.22M$36.11M$36.70M-$720.0K
EPS (Diluted)-$0.83$1.27-$0.19$0.20$113.44$0.97$0.41$0.34$0.45-$0.01
Total Assets$8.54B$12.34B$13.61B$14.03B$16.76B$1.90B$452.30M$369.78M$299.22M$211.35M
Total Liabilities$2.15B$2.04B$1.97B$1.79B$3.21B$781.20M$100.10M$77.85M$122.08M$81.69M
Long-Term Debt$494.86M$375.76M$253.91M$11.81M$15.77M$35.10M$5.93M$7.21M$33.00M$40.73M
Shareholders' Equity$6.40B$10.29B$11.64B$12.24B$13.55B$1.12B$352.19M$291.93M$177.14M$129.67M
Cash & Equivalents$488.25M$335.27M$1.12B$3.88B$11.61B$1.04B$152.72M$158.17M$114.42M$62.43M
Operating Cash Flow-$512.18M-$56.89M$138.65M-$798.12M$15.32B$479.31M$39.07M$7.94M$59.76M-$13.90M
Capital Expenditures$48.92M$95.96M$156.16M$313.86M$594.21M$127.49M$10.63M$5.61M$11.91M$12.65M
Free Cash Flow-$561.10M-$152.85M-$17.52M-$1.11B$14.73B$351.82M$28.45M$2.33M$47.84M-$26.56M
Dividends Paid$3.53B$947.00M$328.08M$247.40M$1.88B$0$0n/an/an/a
Shares Outstanding71.86M71.86M71.86M71.72M71.72M99.29M98.90M71.14M57.28M57.01M
Dividends Per Share$55.00n/an/an/an/an/an/an/an/an/a
Weighted Average Diluted Shares71.86M71.86M71.85M71.76M71.60M113.66M109.69M64.98M57.10M56.95M
EPS (Basic)-$0.83$1.27-$0.19$0.20$113.54$1.06$0.42$0.34$0.45-$0.01

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView